Qube Research & Technologies LTD Bristol Myers Squibb CO Put Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $40.3 Million - $52.6 Million	-1,017,300 Reduced 50.6%	993,200 $51.4 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $16.4 Million - $21.5 Million	406,600 Added 25.35%	2,010,500 $83.5 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $47 Million - $53.3 Million	980,000 Added 157.08%	1,603,900 $87 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $17.4 Million - $20.7 Million	358,000 Added 134.64%	623,900 $32 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $15.3 Million - $17.2 Million	265,000 Added 29444.44%	265,900 $15.4 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $59,138 - $67,077	900 New	900 $62,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.